Bottom line
Is HBIOX a good fund? The bottom line
HBIOX is the IB share class of Hartford International Opportunities Hls Fund, a managed international stock mutual fund from Hartford.
Annual fees run 1.01% — about $101 a year on every $10,000 invested, more expensive than 61% of international stock funds we track.
It returned +30.1% over one year, +6.6% a year over five years, +7.9% a year over ten (as of Dec 31, 2025, per its prospectus).
With $870 million in net assets and 78 holdings, its largest position is Taiwan Semiconductor Manufacturing Co Ltd (7.4%) and the top 10 make up 29.3% of the portfolio.
The closest lower-cost alternative we found is FSGGX (0.055%, 50% top-holdings overlap).
What to watch
- 12b-1 marketing fee of 0.25% a year
Updated Nov 19, 2026
What HBIOX invests in
The Fund seeks long-term growth of capital.
The Fund normally invests at least 65% of its net assets in equity securities, including non-dollar securities, of foreign issuers. The Fund diversifies its investments among a number of different countries throughout the world, with no limit on the amount of assets that may be invested in each country. The securities in which the Fund invests are denominated in both U.S. dollars and foreign currencies and generally are traded in foreign markets. The Fund may invest in companies domiciled in emerging markets as a percentage of its net assets up to the greater of: (a) 25% or (b) the weight of emerging markets in the MSCI ACWI ex USA Index plus 10%. The Fund may invest in opportunities across the market capitalization spectrum, but under normal circumstances invests primarily in mid and large capitalization companies. The sub-adviser, Wellington Management Company LLP (Wellington…
From the fund's prospectus (filed Apr 14, 2026).
HBIOX performance
| 1 yr | 5 yr | 10 yr | |
|---|---|---|---|
| HBIOX | +30.1% | +6.6% | +7.9% |
| International Stock median | +25.5% | +6.4% | +7.6% |
Source: Fund prospectus, as of Dec 31, 2025
What HBIOX costs
On a $10,000 investment, HBIOX's 1.01% expense ratio costs about $101 a year. The prospectus estimates $1,236 in total costs over 10 years (assuming 5% annual returns). The median international stock fund charges 0.9%.
HBIOX top 10 holdings
| # | Holding | % of fund |
|---|---|---|
| 1 | Taiwan Semiconductor Manufacturing Co Ltd | 7.36% |
| 2 | SK hynix Inc | 4.32% |
| 3 | ASML Holding NV | 3.39% |
| 4 | Samsung Electronics Co Ltd | 3.14% |
| 5 | Royal Bank of Canada | 2.24% |
| 6 | Tencent Holdings Ltd | 1.86% |
| 7 | Siemens AG | 1.79% |
| 8 | AstraZeneca PLC | 1.77% |
| 9 | TotalEnergies SE | 1.75% |
| 10 | Societe Generale SA | 1.72% |
Source: SEC Form N-PORT, period ended Jun 30, 2026
The top 10 make up 29.3% of the fund. See all top 25 holdings and asset mix →